Pattern of brain-specific protein modifications is driven by the regulation of multiple enzymes

May 02, 2014
Figure 1: In the brain, epigenetic factors can increase expression of the enzyme GnT-IX to produce a specific glycosylation pattern (left), or block GnT-IX expression to prevent the same glycosylation process (right). Credit: Yasuhiko Kizuka, RIKEN–Max Planck Joint Research Center for Systems Chemical Biology

(Phys.org) —Many human proteins are modified by the attachment of short sugar chains called glycans. The patterns of attachment, or glycosylations, are known to be specific to organs, tissues and cell types, but the mechanisms regulating these patterns have been unclear. Naoyuki Taniguchi, Yasuhiko Kizuka and colleagues from the RIKEN–Max Planck Joint Research Center for Systems Chemical Biology have now clarified one such mechanism in the brain.

Glycosylation is mediated by glycosyltransferase enzymes. The researchers studied one of these enzymes called N-acetylglucosaminyltransferase-IX (GnT-IX), which is expressed only in the brain and is involved in demyelination—degradation of the insulation around neurons that helps them to conduct electrical signals. Understanding the regulation of GnT-IX could help in developing better knowledge of diseases such as multiple sclerosis.

As Kizuka explains, a closer look at the process regulating GnT-IX expression could also provide broader insight into glycosylation. "Expression of each glycosyltransferase enzyme in a specific tissue contributes to the phenomenon of tissue-specific glycosylation," he says. "Unveiling the mechanism of how GnT-IX is present only in the brain could lead to a general understanding of how are formed in a tissue-specific manner."

The team focused on a process known as epigenetics, in which is altered over time by modification of DNA and the histone proteins they are wrapped around. By manipulating expression of epigenetic factors in cultured brain cells and measuring the effect on GnT-IX expression, the researchers found that an enzyme called histone deacetylase 11 (HDAC11), which modifies histones near the GnT-IX gene, blocks expression of the GnT-IX . In contrast, enzymes called ten eleven translocase 3 (TET3) and O-GlcNAc transferase (OGT) increase expression of GnT-IX by recruiting a protein called NeuroD1, which triggers expression of the GnT-IX gene. The expression of enzymes similar to GnT-IX was unaffected, showing that this control mechanism is highly specific (Fig. 1).

"For the first time, we revealed the epigenetic mechanism underlying tissue-specific glycosylation," says Kizuka. "I expect that similar epigenetic mechanisms regulate other glycosylation-related genes, and analyzing the regulation of these genes will promote our understanding of glycosylation."

Kizuka also notes that it could be this epigenetic mechanism of GnT-IX regulation that goes wrong in the development of demyelination diseases. If similar mechanisms operate for other enzymes, there could be wider implications. "Defects in glycosylation often lead to severe disorders," he says. "Some of these diseases might be triggered by epigenetic dysregulation of -related genes."

Explore further: Research team identifies new genetic syndrome

More information: Kizuka, Y., Kitazume, S., Okahara, K., Villagra, A., Sotomayor, E. M. & Taniguchi, N. "Epigenetic regulation of a brain-specific glycosyltransferase N-acetylglucosaminyltransferase-IX (GnT-IX) by specific chromatin modifiers." Journal of Biological Chemistry 289, 11253–11261 (2014). DOI: 10.1074/jbc.M114.554311

add to favorites email to friend print save as pdf

Related Stories

Unearthing a path leading to diabetes

Jan 06, 2012

A molecular mechanism that links diet, obesity and diabetes involves depletion of specialized ‘transporter proteins’, a Japanese–American team has found. Transporter proteins deliver glucose ...

Homing in on developmental epigenetics

Aug 23, 2013

Germ cells have unique molecular features that enable them to perform the important task of transmitting genetic information to the next generation. During development from their embryonic primordial state, ...

Research team identifies new genetic syndrome

Mar 04, 2014

Researchers at the National Institutes of Health (NIH) have identified a new genetic syndrome characterized by a constellation of health problems, including severe allergy, immune deficiency, autoimmunity and motor and neurocognitive ...

Recommended for you

Jumping hurdles in the RNA world

Nov 21, 2014

Astrobiologists have shown that the formation of RNA from prebiotic reactions may not be as problematic as scientists once thought.

New computer model sets new precedent in drug discovery

Nov 18, 2014

A major challenge faced by the pharmaceutical industry has been how to rationally design and select protein molecules to create effective biologic drug therapies while reducing unintended side effects - a challenge that has ...

Finding new ways to make drugs

Nov 18, 2014

Chemists have developed a revolutionary new way to manufacture natural chemicals and used it to assemble a scarce anti-inflammatory drug with potential to treat cancer and malaria.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.